Europe Veterinary Dermatology Drugs Market Size & Outlook

The veterinary dermatology drugs market in Europe is expected to reach a projected revenue of US$ 8,447.4 millions by 2030. A compound annual growth rate of 8.2% is expected of Europe veterinary dermatology drugs market from 2023 to 2030.
Revenue, 2022 (US$Ms)
$4,493.4
Forecast, 2030 (US$Ms)
$8,447.4
CAGR, 2023 - 2030
8.2%
Report Coverage
Europe

Europe veterinary dermatology drugs market, 2018-2030 (US$Ms)

Europe

Europe veterinary dermatology drugs market highlights

  • The Europe veterinary dermatology drugs market generated a revenue of USD 4,493.4 millions in 2022.
  • The market is expected to grow at a CAGR of 8.2% from 2023 to 2030.
  • In terms of segment, parasitic infections was the largest revenue generating indication in 2022.
  • Allergic Infections is the most lucrative indication segment registering the fastest growth during the forecast period.
  • Country-wise, Germany is expected to register the highest CAGR from 2023 to 2030.


Europe data book summary

Market revenue in 2022USD 4,493.4 millions
Market revenue in 2030USD 8,447.4 millions
Growth rate8.2% (CAGR from 2022 to 2030)
Largest segmentParasitic infections
Fastest growing segmentAllergic Infections
Historical data covered2018 - 2021
Base year for estimation2022
Forecast period covered2023 - 2030
Quantitative unitsRevenue in USD millions
Market segmentationParasitic Infections, Allergic Infections
Key market players worldwideElanco Animal Health Inc, CEVA Inc, Vetoquinol SA, Merck & Co Inc, Zoetis Inc Class A, Virbac SA, Bimeda, Bioiberica, Boehringer Ingelheim Pharma


Other key industry trends

  • In terms of revenue, Europe region accounted for 30.2% of the global veterinary dermatology drugs market in 2022.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 6,215.0 millions by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Veterinary Dermatology Drugs Market Companies

Name Profile # Employees HQ Website

Europe veterinary dermatology drugs market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary dermatology drugs market will help companies and investors design strategic landscapes.


Parasitic infections was the largest segment with a revenue share of 42.79% in 2022. Horizon Databook has segmented the Europe veterinary dermatology drugs market based on parasitic infections, allergic infections covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to Europe veterinary dermatology drugs market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe veterinary dermatology drugs market databook

  • Our clientele includes a mix of veterinary dermatology drugs market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe veterinary dermatology drugs market, including forecasts for subscribers. This continent databook contains high-level insights into Europe veterinary dermatology drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe veterinary dermatology drugs market report size, by country, 2018-2030 (US$Ms)

Europe Veterinary Dermatology Drugs Market Share, 2022 & 2030 (US$Ms)

Europe veterinary dermatology drugs market report size, by country, 2018-2030 (US$Ms)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more